儿童膀胱内注射超声造影剂Optison™行对比增强排尿超声诊断膀胱输尿管反流的前瞻性临床试验
这项在美国开展的前瞻性比较研究纳入30例儿童(62个肾盂输尿管单位),评估膀胱内注射0.2% Optison™/生理盐水行对比增强排尿超声(ceVUS)诊断膀胱输尿管反流(VUR)的诊断性能与安全性,并以排尿性膀胱尿道造影(VCUG)为参考标准。ceVUS诊断VUR的敏感度为91.7%(95%CI:61.5%-99.8%),特异度为98%(95%CI:89.4%-99.9%);未发生严重不良事件,48小时随访1例(3.3%)报告一过性排尿困难。作者认为Optison™ ceVUS对VUR的检出与VCUG相当,且无电离辐射暴露、耐受性良好。
要点
- 以VCUG为参考标准,Optison™ ceVUS检出VUR的敏感度91.7%、特异度98%。
- ceVUS与VCUG对VUR检出和分级的符合率分别为84.3%和81.8%。
- 62个肾盂输尿管单位中11个存在反流,其中4个ceVUS与VCUG分级不一致,2个由VCUG上调分级。
核心结论
- 使用Optison™行ceVUS检出VUR与VCUG相当,且无电离辐射暴露;Optison™ ceVUS是一种耐受性良好、安全性好的诊断方法。
研究设计与样本
- 美国FDA及机构研究性新药授权下开展的前瞻性比较研究,纳入30例患者共62个肾盂输尿管单位,平均年龄3.5岁(范围0.1-17岁),其中女童21例、男童9例;ceVUS采用膀胱内注射0.2% Optison™/生理盐水溶液,随后行标准VCUG,以VCUG为参考标准。
诊断标准与关键数值
- 以VCUG为参考标准,ceVUS诊断VUR的敏感度为91.7%(95%CI:61.5%-99.8%),特异度为98%(95%CI:89.4%-99.9%);ceVUS与VCUG对VUR检出和分级的符合率分别为84.3%和81.8%。
临床应用与阅片要点
- 检查前后及检查期间监测心率、脉搏血氧饱和度和不良反应,并在检查后48小时经电话完成随访问卷。
局限性
- 膀胱输尿管反流分级不一致见于4/11个反流肾盂输尿管单位,其中2个由VCUG上调VUR分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Contrast-enhanced voiding urosonography (ceVUS) is widely used outside the United States to diagnose vesicoureteral reflux (VUR) in children and is highly sensitive while avoiding exposure to ionizing radiation. At the onset of this study, two ultrasound (US) contrast agents were available in the United States. Pediatric safety data for intravenous administration was published for one, Optison™.
OBJECTIVE: This study aimed to evaluate the diagnostic performance and safety of ceVUS using Optison™ and compare its diagnostic efficacy with voiding cystourethrogram (VCUG) for VUR detection and grading in children.
MATERIALS AND METHODS: The United States Food and Drug Administration and institutional Investigational New Drug authorizations were obtained to conduct a prospective comparative study of ceVUS with Optison™ and VCUG. CeVUS was performed with intravesical administration of 0.2% Optison™/normal saline solution. A standard VCUG followed. Safety assessment included physical examination, and heart rate, pulse oximetry and adverse reactions monitoring before, during and immediately after the examinations. A follow-up questionnaire was completed by telephone 48-h after the studies.
RESULTS: Sixty-two pelviureteric units were studied in 30 patients with a mean age of 3.5 years (range: 0.1-17 years) including 21 girls and 9 boys. No severe adverse events occurred. All patients had normal heart rate and blood oxygenation saturation prior to, during and after the studies. At the 48-h follow-up, one patient (3.3%) reported transient dysuria. Taking the VCUG as the reference standard, ceVUS had a sensitivity of 91.7% (95%; confidence interval [CI]: 61.5%-99.8%) and specificity of 98% (95%; CI: 89.4%-99.9%). The concordance between ceVUS and VCUG for VUR detection and grading was 84.3% and 81.8%, respectively. VUR grades were discrepant in 4/11 refluxing pelviureteric units, with VCUG upgrading VUR in 2.
CONCLUSION: Detection of VUR with Optison™ ceVUS was comparable to VCUG without exposure to ionizing radiation. CeVUS with Optison™ is a well-tolerated diagnostic procedure with a favorable safety profile.
引用
- Ntoulia A, Back SJ, Shellikeri S, et al. Contrast-enhanced voiding urosonography (ceVUS) with the intravesical administration of the ultrasound contrast agent Optison™ for vesicoureteral reflux detection in children: a prospective clinical trial. Pediatr Radiol. 2017. PMID: 29181582. doi:10.1007/s00247-017-4026-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。